双能量CT预测颈动脉支架内再狭窄:一项多中心研究
本研究为回顾性多中心研究,纳入2018年1月至2023年4月接受颈动脉支架置入术的205例患者,术前进行双能量CT扫描。多因素分析确定斑块长度、脂肪分数、归一化碘浓度和有效原子序数为支架内再狭窄的独立预测因子,联合临床与双能量CT参数的列线图模型在训练集和验证集的AUC分别为0.931和0.872,优于临床模型和双能量CT模型。结论认为该列线图模型可为颈动脉支架置入术后支架内再狭窄风险预测提供可靠的无创工具。
要点
- 列线图模型联合临床与双能量CT参数预测支架内再狭窄,训练集AUC 0.931,验证集AUC 0.872。
- 斑块长度、脂肪分数、归一化碘浓度和有效原子序数为支架内再狭窄的独立预测因子。
- 列线图模型预测效能优于临床模型(训练集AUC 0.797,验证集0.673)和双能量CT模型(训练集AUC 0.880,验证集0.853)。
核心结论
- 整合双能量CT参数与临床预测因子的列线图模型为颈动脉支架置入术后支架内再狭窄风险预测提供了可靠的无创工具,有助于制定个体化治疗策略并为早期干预提供重要参考。
研究设计与样本
- 回顾性多中心研究,纳入2018年1月至2023年4月接受颈动脉支架置入术的205例患者,术前进行双能量CT扫描,由两名放射科医师独立测量双能量CT参数并评估颈动脉斑块特征,通过单因素和多因素分析筛选独立预测因子,构建临床模型、双能量CT模型和列线图模型三种模型。
诊断标准与关键数值
- 列线图模型预测支架内再狭窄的AUC在训练集为0.931(95% CI:0.878-0.966),在验证集为0.872(95% CI:0.754-0.947)。
- 临床模型预测支架内再狭窄的AUC在训练集为0.797,在验证集为0.673。
- 双能量CT模型预测支架内再狭窄的AUC在训练集为0.880,在验证集为0.853。
- 多因素分析确定斑块长度、脂肪分数、归一化碘浓度和有效原子序数为支架内再狭窄的独立预测因子。
临床应用与阅片要点
- 列线图模型可作为预测支架内再狭窄风险的有效工具,以指导个体化治疗。
- 作者认为该模型可能有助于减少支架内再狭窄相关卒中并改善颈动脉支架置入术 outcomes。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
OBJECTIVES: Our work aimed to assess the clinical value of dual-energy computed tomography (DECT) parameters in predicting in-stent restenosis (ISR) after carotid artery stenting (CAS) and to develop a nomogram model incorporating these parameters to enhance the accuracy of ISR risk prediction.
MATERIALS AND METHODS: Our retrospective multicenter research enrolled 205 patients who underwent CAS from January 2018 to April 2023, with DECT scans performed prior to the procedure. Two radiologists independently measured the DECT parameters and evaluated the characteristics of carotid plaques. Univariate and multivariate analyses were conducted to identify independent predictors of ISR. Three models were developed: clinical model, DECT model, and nomogram model. These models were assessed based on the area under the curve (AUC) and calibration, with their clinical value assessed utilizing decision curve analysis (DCA).
RESULTS: Among 205 patients, 35 in the training set and 15 in the validation set experienced ISR. Multivariate analysis identified plaque length, fat fraction, normalized iodine concentration, and effective atomic number as independent predictors of ISR. Nomogram model, combining clinical and DECT parameters, demonstrated high accuracy in predicting ISR, with 0.931 (95% CI: 0.878-0.966) AUC in the training set and 0.872 (95% CI: 0.754-0.947) in the validation set, exceeding both clinical (AUC: 0.797, 0.673) and DECT models (AUC: 0.880, 0.853). Calibration curve and DCA exhibited the nomogram's excellent performance and clinical utility.
CONCLUSION: The nomogram model integrating DECT parameters and clinical predictors provides a reliable and noninvasive tool for predicting ISR risk following CAS. It facilitates the formulation of individualized treatment strategies and offers important references for early intervention.
KEY POINTS: Question Preoperative prediction of in-stent restenosis (ISR) risk after carotid artery stenting is critical for optimizing revascularization strategies, yet current assessment methods remain limited and subjective. Findings The nomogram incorporating plaque length, fat fraction, normalized iodine, and effective atomic number for predicting ISR risk achieved AUCs of 0.931 and 0.872 in the training and validation sets. Clinical relevance This nomogram can serve as an effective tool for predicting ISR risk to guide personalized treatment, potentially reducing ISR-related strokes and improving carotid stenting outcomes.
引用
- Hu W, Lin G, Chen W, et al. Predicting carotid in-stent restenosis with dual-energy CT: a multicenter study. Eur Radiol. 2025. PMID: 41198863. doi:10.1007/s00330-025-12109-8
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。